AEs increase economic burden in patients with CLL

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      2018 US dollars

    Reference

    1. Kabadi SM, et al. Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study. Advances in Therapy : 12 May 2020. Available from: URL: http://doi.oeg/10.1007/s12325-020-01350-w

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    AEs increase economic burden in patients with CLL. PharmacoEcon Outcomes News 854, 4 (2020). https://doi.org/10.1007/s40274-020-6834-1

    Download citation